Comprehensive
Heart Health Analytics
for Greater Longevity
Cardiolyse is a cloud ECG & HRV analytics platform, that enables real-time remote heart health monitoring, providing plain personalized reports, detection and up to two months data-based prognosis on dangerous heart events
We deliver a holistic approach to prevent heart disorders for elevated risk groups, using innovative and clinically proven machine-learning algorithms
Monitor
Cloud solution for affordable real-time remote heart health monitoring through any leads digital ECG device integration
Analyze
Clinically proven machine-learning algorithms that analyze up to 400 vital ECG parameters and detect all types of Arrythmias, Atrial Fibrillation, Myocardial Infarction, Ventricular Hypertrophy
Predict
Patent-pending Universal ECG and Personal Baseline Scores to precisely predict heart attacks and strokes up to 2 months before they occur
Prevent
Personalized reports on vital cardiac parameters values to timely adjust medication and patient's lifestyle, increasing access to preventive care
Remote Real-time Heart Health Monitoring
Allows to accurately determine the position of every cardiac parameter on a scale from a personal baseline to pathology to prevent dangerous heart events for elevated risk groups
Diabetes Cardiovascular Comorbidities Prevention
Provides an integrated solution for primary prevention of cardiovascular complications in diabetes with specific cardiac parameters monitoring, timely disease CVD risk detection and cure
Fatigue Risk Management
Comprehensive liability insurance solution and alert system for seamless real-time fatigue risks monitoring in critical safety job performers to prevent further accidents
Benefits
for corporate sector
Comprehensive clinically-proven and CE-certified, yet affordable tracking of all-known vital parameters to ease and speed-up the patient diagnosticating for cardiologists, general practitioners and healthcare providers
Healthcare system cost burden reduction, driven by eliminated physician office visits, dangerous heart events and hospital readmission prevention with timely cardiovascular risk detection and early treatment intervention
Plain, patient- and doctor-adapted visually compelling cardiac health reports, enabling patients to take control of and positively impact their health with necessary lifestyle adjustments
Team
Meet our health passionate and expert global team, standing behind the Cardiolyse platform development and growth
Advisory Board
Pulli Global Development Advisor Executive with 25+ years of experience in Business Development (ex-CEO Chiezi)
Pirttiaho Global Development Advisor MedTech solutions growth expert with 15+ years in sales for large and small ventures
Gualerzi Scientific Advisor Experienced medical director and cardiologist, leading non-profit's and corporate scientific divisions
News
Cardiolyse crowdfunding open on Aescuvest.de
Happy to announce we’ve just opened a crowdfunding campaign on the Aescuvest platform! We’ve been looking forward to this day as it gives us all opportunity to shape the future of Cardiovascular Health together! Aescuvest is the first pan-European digital venture capital platform in the healthcare space, dedicated to actively shaping the future of health in Europe and we are happy to be […]
Read more
Cardiolyse shows a successful pilot project at EXPO 6 Startup Creasphere by Plug and Play
As a result of a 3-months accelerator program Cardiolyse showcased the outcome of our pilot at Munich Summer Summit. Startup Creasphere: Established in 2018 by Roche Diagnostics and Plug and Play, Startup Creasphere is the first healthcare-focused innovation platform in Munich. Startup Creasphere creates an environment within the global network of Plug and Play where corporations and startups learn and […]
Read more
EIT Health Catapult 2021 selects Cardiolyse for the semi-final
We will receive intensive training from experts, meet investors and corporates, and compete in pitch contests to progress to the finals. The EIT Health Catapult, currently in its sixth year, is a training and competition programme that boosts the development of European health start-ups by exposing them to top-quality experts and international investors. The programme has already supported over 189 start-ups […]
Read more
Cardiolyse is chosen for the first edition of the Health&Biotech accelerator by Deloitte Italy
Cardiolyse is one of 6 international startups chosen among over 350 applicants, that will participate in the Health&BioTech Accelerator’s program coordinated by Deloitte Officine Innovazione in collaboration with MSD Italia, Intesa Sanpaolo RBM Salute, and some of the largest private healthcare providers in the Country such as Gruppo San Donato. The initiative is also supported by the clinical partners Humanitas and Santagostino, by the Italian Institue of […]
Read more
Startup Creasphere by Plug and Play selects Cardiolyse for their 3-months-program
Startup Creasphere, Europe’s largest healthcare innovation platform kicks off Batch 6. The corporate partners selected 17 startups for the 3-months-program and Cardiolyse is one of the winners! A total of 38 applications were received from a wide range of organisations across Europe. For the next 3 months, we’ll be working on co-creation with a corporate partner, receiving coaching and mentoring, […]
Read moreSend us a word regarding any question or suggestion you have
Let’s work together
on heart health improvement